Surmodics Total Assets 2006-2020 | SRDX

Surmodics total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Surmodics Annual Total Assets
(Millions of US $)
2019 $160
2018 $164
2017 $137
2016 $133
2015 $99
2014 $105
2013 $102
2012 $104
2011 $157
2010 $170
2009 $186
2008 $191
2007 $171
2006 $157
2005 $124
Surmodics Quarterly Total Assets
(Millions of US $)
2020-03-31 $156
2019-12-31 $155
2019-09-30 $160
2019-06-30 $150
2019-03-31 $151
2018-12-31 $151
2018-09-30 $164
2018-06-30 $160
2018-03-31 $163
2017-12-31 $135
2017-09-30 $137
2017-06-30 $132
2017-03-31 $131
2016-12-31 $129
2016-09-30 $133
2016-06-30 $127
2016-03-31 $122
2015-12-31 $112
2015-09-30 $99
2015-06-30 $96
2015-03-31 $91
2014-12-31 $87
2014-09-30 $105
2014-06-30 $101
2014-03-31 $96
2013-12-31 $95
2013-09-30 $102
2013-06-30 $104
2013-03-31 $108
2012-12-31 $108
2012-09-30 $104
2012-06-30 $158
2012-03-31 $154
2011-12-31 $152
2011-09-30 $157
2011-06-30 $173
2011-03-31 $172
2010-12-31 $172
2010-09-30 $170
2010-06-30 $191
2010-03-31 $191
2009-12-31 $191
2009-09-30 $186
2009-06-30 $182
2009-03-31 $182
2008-12-31 $180
2008-09-30 $191
2008-06-30 $195
2008-03-31 $185
2007-12-31 $174
2007-09-30 $171
2007-06-30 $165
2007-03-31 $138
2006-12-31 $152
2006-09-30 $157
2006-06-30 $144
2006-03-31 $136
2005-12-31 $131
2005-09-30 $124
2005-06-30 $118
2005-03-31 $109
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.562B $0.100B
SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $165.688B 28.73
Medtronic (MDT) Ireland $120.891B 19.64
Stryker (SYK) United States $66.633B 21.63
Boston Scientific (BSX) United States $48.278B 22.70
Baxter (BAX) United States $43.462B 26.53
Lonza Group Ag (LZAGY) Switzerland $42.008B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $28.981B 0.00
Terumo (TRUMY) Japan $28.231B 36.09
ResMed (RMD) United States $28.021B 44.22
Zimmer Biomet Holdings (ZBH) United States $24.281B 15.28
Sunny Optical Technology (SNPTF) China $20.840B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.828B 0.00
Bio-Rad Laboratories (BIO) United States $14.172B 64.51
Insulet (PODD) United States $13.329B 1320.56
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $10.288B 80.85
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
GN STORE NORD (GNNDY) Denmark $7.676B 39.13
Perrigo (PRGO) Ireland $7.396B 13.23
Hill-Rom Holdings (HRC) United States $7.394B 20.84
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.620B 0.00
Haemonetics (HAE) United States $4.381B 26.31
Neogen (NEOG) United States $4.079B 69.10
GW Pharmaceuticals (GWPH) United Kingdom $3.977B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.923B 0.00
ICU Medical (ICUI) United States $3.761B 27.44
Agios Pharmaceuticals (AGIO) United States $3.676B 0.00
Envista Holdings (NVST) United States $3.138B 0.00
NuVasive (NUVA) United States $2.743B 22.03
TG Therapeutics (TGTX) United States $2.661B 0.00
National Vision Holdings (EYE) United States $2.237B 38.71
AtriCure (ATRC) United States $1.768B 0.00
MacroGenics (MGNX) United States $1.508B 0.00
NanoString Technologies (NSTG) United States $1.361B 0.00
Aurora Cannabis (ACB) Canada $1.333B 0.00
Aphria (APHA) Canada $1.206B 0.00
Cerus (CERS) United States $1.148B 0.00
Meridian Bioscience (VIVO) United States $1.069B 40.24
Cardiovascular Systems (CSII) United States $1.042B 0.00
Vapotherm (VAPO) United States $1.014B 0.00
Phibro Animal Health (PAHC) United States $0.996B 19.85
PetIQ (PETQ) United States $0.961B 27.75
DFB Healthcare Acquisitions (AHCO) United States $0.890B 148.08
OraSure Technologies (OSUR) United States $0.860B 173.13
Zynex (ZYXI) United States $0.853B 85.70
InMode (INMD) Israel $0.853B 18.02
Quanterix (QTRX) United States $0.779B 0.00
Omeros (OMER) United States $0.731B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.646B 46.29
BioLife Solutions (BLFS) United States $0.572B 162.82
VAREX IMAGING (VREX) United States $0.571B 14.18
Lantheus Holdings (LNTH) United States $0.571B 11.49
LeMaitre Vascular (LMAT) United States $0.521B 29.67
Owens & Minor (OMI) United States $0.466B 12.33
Viemed Healthcare (VMD) United States $0.413B 36.62
Cytosorbents (CTSO) United States $0.368B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.343B 0.00
HEXO (HEXO) $0.328B 0.00
Utah Medical Products (UTMD) United States $0.302B 21.90
Organigram Holdings (OGI) Canada $0.262B 0.00
InfuSystems Holdings (INFU) United States $0.224B 124.11
Female Health (VERU) United States $0.209B 0.00
Chimerix (CMRX) United States $0.192B 0.00
Surface Oncology (SURF) United States $0.161B 0.00
Bovie Medical (APYX) United States $0.158B 0.00
Fonar (FONR) United States $0.134B 11.83
Exagen (XGN) United States $0.133B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
United Health Products (UEEC) United States $0.117B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.114B 0.00
Liberty Health Sciences (LHSIF) Canada $0.108B 0.00
Wound Management Technologies (SMTI) United States $0.104B 0.00
Evolus (EOLS) United States $0.102B 0.00
MTech Acquisition (KERN) United States $0.096B 0.00
Chembio Diagnostics (CEMI) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.080B 0.00
Nephros (NEPH) United States $0.068B 0.00
United-Guardian (UG) United States $0.066B 15.32
Capricor Therapeutics (CAPR) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 0.00
Brainsway (BWAY) Israel $0.060B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00